Nanose Medical

Nanose construye una plataforma de detección impulsada por IA que permite la detección temprana del riesgo de cáncer de pulmón y fibrosis hepática avanzada (MASLD/MASH) en el punto de atención.

Nuestra tecnología de detección patentada genera una huella bioquímica del aliento a partir de una muestra de 30 segundos con resultados en menos de 5 minutos , lo que permite una estratificación escalable de p...

País

Israel

Sitio web

nanosemed.com

Fundado

2019

Sociales

Fuente de información:

https://nanosemed.com/

Añadir a mi lista

Ejecutivos clave

Ilay Marom

Co-founder & COO

Orit Marom Albeck

Co-Founder and CEO

Imad Telhami

Co-Founder & Board member

Industrias

Biotech

Med Tech

GoforIsrael

Noticias y actividades recientes

News Feb , 2022

The Marker - ה"אף האלקטרוני" יציל חיים: החיישנים הננו-מטריים יתריעו על מחלות וזיהומים באמצעות הרחה בלבד

News May , 2025

ctech - "Running a startup is like going to war—you need teammates who don’t give up when things get hard" | CTech

News Jun , 2025

ctech - “We want to be in every clinic”: The Israeli startup out to change early disease detection | CTech

Agregue tu empresa

Disclaimer

The content of this website is not directed at or intended for persons in the United Kingdom or any other jurisdiction where the provision of the website or services would breach any applicable law or registration or would require any registration or license in any such jurisdiction. The content of this website should not be regarded as an invitation or inducement to engage in investment activity, to any person in the United Kingdom and investment opportunities described on this website are not intended to be acted upon by any persons in the United Kingdom.